Oxaliplatin Injection, Solution
Product Images NDC 0781-3317

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxaliplatin (NDC 0781-3317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxaliplatin Sandoz 01

FDA Label Image

Oxaliplatin Sandoz 02

This description represents the probability of Disease-Free Survival (DFS) in patients treated with FOLFOX4 or LV5FU2. It shows the percentage of events and number of patients at risk, which suggests the effectiveness of both treatment options. Hazard ratios and stratified logrank test indicate that FOLFOX4 had a lower hazard ratio, and hence, may indicate better effectiveness. The graph shows the number of events over time for each treatment, with annotations mentioning the number of patients at risk in different intervals of time.*

FDA Label Image

Oxaliplatin Sandoz 03

The provided text seems to be a graph or chart displaying the probability of DFS (Disease-Free Survival) for a specific treatment, with corresponding hazard ratios and a logrank test. Unfortunately, without proper context or axis labels, it's not possible to determine much more beyond that.*

FDA Label Image

Oxaliplatin Sandoz 04

This text shows the survival rate of patients undergoing different treatments. It includes a graph showing percentages of patients surviving over a certain number of months and the median survival time for each treatment. The treatments compared are oxaliplatin + 5-FU/LV, irinotecan + 5-FU/LV, and oxaliplatin + irinotecan. The text also mentions a log rank test comparing the survival rates of oxaliplatin plus 5-FU/LV to irinotecan plus 5-FU/LV.*

FDA Label Image

Oxaliplatin Sandoz 05

This is a prescription intravenous medication called Oxaliplatin, which is a Cytotoxic Agent. It comes in a single-dose vial that contains 5mg of Oxaliplatin per ml of a sterile, preservative-free aqueous solution. The usual dosage and further dilution information can be found in the package insert. It should be stored at temperatures between 15 to 30°C, and should be protected from light. Unused portions should be discarded as described in the package insert.*

FDA Label Image

Oxaliplatin Sandoz 06

This is a pharmaceutical product with the active ingredient Oxaliplatin, used for intravenous injection. It comes in a single-dose vial of 100mg/20mL and requires further dilution before use. It is a cytotoxic agent and should be kept out of the reach of children. It should be stored at a temperature between 15°C and 30°C. Only sodium chloride/ aqueous solutions should be used, and unused portions should be discarded. The product has a control number and is manufactured by Sandoz.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.